APPROACH

My orientation and philosophy are centered around the idea that - because of how our modern society operates - there is now a large gap between what time, energy, and resources we have and what our brains and bodies were meant for. What we call symptoms are often a signal that something is out of alignment. I aim to help patients, families, and communities identify these gaps and what work could be done together, leveraging strengths and a community of care, to work toward collective healing.

I see my role overall as a co-investigator, as part of a team working with you, the natural workings of your mind, body, spirit, and lifestyle, other healthcare providers and therapists, and supports in your life to understand your journey.

Above all else, I believe in the power of relationships in the path toward wholeness, which is why I focus on regular, long-term therapeutic work with patients. In my practice I do a very thorough, often ongoing assessment, and then use a variety of therapy modalities, medications that are both prescribed and integrative, expanded states of consciousness, and suggestions for lifestyle changes as aids.

I work best with patients and families who are committed to their health and wellness, and wish to invest in a partnership on the path to long-term growth.

Dr. Jamarie Geller, MD, MA

I am a contemplative child, adolescent, and adult psychiatrist and psychotherapist whose highest values are community, connection, authenticity, compassion, and play.

I embarked on 17 years of education in medicine and mental health and healing because I believe in possibility. My passion lies most in true integration — when science, soul, community, and relational attunement meet. I find great joy in learning about other people and fulfillment in sitting with their stories. I also love learning about different healing philosophies and modalities, and thinking deeply with patients about what tools may be most useful now.

TRAINING AND CREDENTIALS

  • Chief Fellow at the University of Michigan

  • The University of Michigan

  • Michigan State University College of Human Medicine

  • Contemplative Psychotherapy from Naropa University

  • Board Certified in Psychiatry from the American Board of Psychiatry and Neurology

    • Pacilio, R., Parikh, S., & Geller, J. (2025). Outpatient ketamine prescribing practices in psychiatry in the United States: A nationwide survey study. Journal of Clinical Psychiatry.  in press) 

    • Pacilio, R. and Geller, J. (2025) Persistent psychosis induced by intravenous ketamine in a patient using cannabis: A case report and literature review. Journal of Clinical Psychopharmacology (in press). 

    • Aday, J. S., McAfee, J., Conroy, D. A., Hosanagar, A., Tarnal, V., Weston, C., ... & Boehnke, K. F. (2025). Preliminary safety and effectiveness of psilocybin-assisted therapy in adults with fibromyalgia: an open-label pilot clinical trial. Frontiers in Pain Research, 6, 1527783.

    • Geller, J. and Whitney, E (2024). Therapeutic Potential of MDMA- and Psychedelic-Assisted Psychotherapy for Adolescent Depression and Trauma. Current Psychiatry Reports, 88-97.

    • Pacilio, R., Lopez, J., Parikh, S., Patel, P., & Geller, J. (2024). Safe ketamine use and pregnancy: A nationwide survey and retrospective review of informed consent, counseling, and testing practices.  The Journal of Clinical Psychiatry, 85(3), 56610.

    • Shannon, S., & Geller, J. (2024). MDMA for PTSD and beyond: a new paradigm brings hope. Frontiers in Human Neuroscience, 18, 1475013.

    • Ince, Y., Geller, J, & Palffy, A., Beser, C., Neville, K., Ziobro, J., and Ghaziuddin, N. (2024). Catatonia and Maintenance ECT in a 15-Year-Old with MED13L Haploinsufficiency Syndrome in the Context of Epilepsy Diathesis. The Journal of ECT. 

    • Geller, J., Glynos, N., Lemmen, A., Pacilio, R., Kruger, D. J., & Hosanagar, A. (2024). Trainees Unprepared for Advances in Psychedelic Medicine: A Survey Study. Journal of Psychoactive Drugs, 1-8.

    • Pfeiffer, P. N., Geller, J., Ganoczy, D., Jagusch, J., Carty, J., Festin, F., Gilmer, W., Martis, B. Ranganathan, M., Wiechers, I. & Hosanagar, A. (2024). Clinical Outcomes of Intravenous Ketamine Treatment for Depression in the VA Health System. The Journal of Clinical Psychiatry, 85(1), 51003

    • Geller, J., Keith, K., Smith, C., Pacilio, R., Arfken, C., Oxley, M., & Mischel, N. (2023). Response to Ketamine Treatment for Major Depressive Disorder Not Associated with Number of Psychiatric Comorbidities. Journal of Affective Disorders Reports 15, 100688.

    • Geller, JA. What are Obsessive-Compulsive and Related Disorders? APA Resource Document Physician Reviewer 2023

    • Keith, K., Geller, J., Froehlich, A., Arfken, C., Oxley, M., and Mischel, N. (2022). Vital Sign ChangesDuring  Intravenous Ketamine Infusions for Depression: An Exploratory Study of Prognostic Indications. Journal of Clinical Psychopharmacology, Vol. 42, No. 3.

    • Geller, J., Starrs, M., Bartholomew, A., Kaliszak, S., & Kessenich, J. (2021) The Health of Haitian Schoolchildren: Longitudinal Effect of Annual Visits on Growth, Journal of Refugee & Global Health: Vol. 4 : Iss. 1, Article 2. 

    • Geller, J., Behere, A. (September, 2019). Our Kids are Wired, For Better or Worse. World Child and AdolescentPsychiatry.

    • Young, S., Pavlik, J., Geller, J., & Mumby, S. American Indian/Alaskan Natives use of Tobacco:  Literature Review (2014). Contract with National Jewish Health investigating this population’s use of the QuitLine

    • Geller, J. (2014)Supporting Clients in Sexual Health, SAMHSA-HRSA Center for Integrated Health Solutions

    • Morris, C., Geller, J., Mumby, S., Kayer, A., & Morris, C. (2015). DIMENSIONS: Well Body Toolkit for Healthcare Providers Supplement, Priority Populations: Justice Involved. Aurora, CO: Behavioral Healthand Wellness Program, University of Colorado Anschutz Medical Campus